Emami Ltd BUY. Market Leader of Cooling Hair Oil, Beating the Heat
|
|
- Hector Quinn
- 5 years ago
- Views:
Transcription
1 Consumer Staples-Household Products Bloomberg Code: HMN IN India Research - Stock Broking Market Leader of Cooling Hair Oil, Beating the Heat High Margin Products in the Portfolio are expected to drive EBITDA growth ahead of Sales growth: Recent acquisition of Kesh King Brand, accounts for around 75% gross margin and 45% EBITDA margin as compared to the other products in the portfolio. Kesh King Brand is expected to drive the top line growth by around 8% to 10% additionally. This will enable Emami to record higher margins in FY17E and FY18E. Marching ahead in the league of Herbal Products: Zandu accounts for ~25% of the total revenue of Emami, with over 200 products in the portfolio under the Zandu Brand. The company is also expected to extend the brand with couple of new products; with the most recent launch of Zandu Honey, Emami is currently test marketing these new products and it is expected to launch these products by the end of FY17E. Market Leader of Cooling Hair oil is beating the Heat: The best seller of all times, Emami s Navratna cooling oil enjoys around 60% of the total market share. The rising temperature across India is expected to give robust growth to its Navratna cooling oil, Navratna Cool Talc and to Boroplus prickly heat powder. Historically, cooling oil has recorded 16% to 17% growth during moderate summer, so considering the current weather condition it is expected to grow at good pace. Valuation and Outlook At CMP of Rs.1007, the stock is trading at P/E of 29.5x for FY18E. With the anticipated increase in top line due to high margin products in the portfolio, rising temperature across India, strong brand positioning, innovation and new product launches which were favourably received by the market, with strong balance sheet & financial ratios, we expect that the consumer expenditure will further increase as the economy revives and hence there will be growth in Emami s top line and bottom line as well. Based on P/E of 38.5x, we initiate the coverage with a BUY rating for a Target Price of Rs.1313 representing an upside of for a period of months. Key Risks ycompetition. yvolatility in raw material prices. Exhibit 1: Valuation Summary YE Mar (Rs. Mn) FY14 FY15 FY16E FY17E FY18E Net Sales EBITDA EBITDA Margin (%) Adj. Net Profit EPS (Rs.) RoE (%) P/E (x) , *Represents multiples for FY14 & FY15 are based on historic market price For private circulation only. For important information about Karvy s rating system and other disclosures refer to the end of this material. Karvy Stock Broking Research is also available on Bloomberg, KRVY<GO>, Thomson Publishers & Reuters Recommendation (Rs.) Apr 30, 2016 BUY CMP (as on Apr 29, 2016) 1007 Target Price 1313 Upside (%) 30 Stock Information Mkt Cap (Rs.mn/US$ mn) / wk High/Low (Rs.) 1368 / 870 3M Avg. daily volume (mn) 0.2 Beta (x) 0.7 Sensex/Nifty / 7850 O/S Shares(mn) Face Value (Rs.) 1.0 Shareholding Pattern (%) Promoters 72.7 FIIs 16.3 DIIs 1.2 Others 9.8 Stock Performance (%) 1M 3M 6M 12M Absolute 10 (0) (4) 7 Relative to Sensex 7 (3) 1 14 Source: Bloomberg Relative Performance* Apr-15 May-15 Jun-15 Source: Bloomberg; *Index 100 Analyst Contact Kunal Jagda Jul Aug-15 Emami Sep-15 Oct-15 Nov-15 Dec-15 kunalnarendra.jagda@karvy.com Jan-16 Feb-16 Sensex Mar-16 Apr-16 1
2 Company Financial Snapshot (Y/E Mar) Profit & Loss (Rs. Mn) FY15 FY16E FY17E FY18E Net sales Optg. Exp (Adj for OI) EBITDA Depreciation Interest Other Income PBT Tax Adj. PAT Profit & Loss Ratios EBITDA margin (%) Net margin (%) P/E (x) EV/EBITDA (x) Dividend yield (%) Balance sheet (Rs. Mn) FY15 FY16E FY17E FY18E Total Assets Net Fixed assets Current assets Other assets Total Liabilities Networth Debt Current Liabilities Other Liabilities Balance Sheet Ratios RoE (%) RoCE (%) Net Debt/Equity (x) (0.3) (0.3) (0.4) (0.4) Equity/Total Assets (%) P/BV (x) Exhibit 2: Shareholding Pattern (%) Company Background Emami Group established in early 1970s, has grown in India, with its presence in major sectors like FMCG, Real Estate, Hospitals, Retail, Newsprint Manufacturing, Pharmacy chain, Contemporary art, Edible oil and biodiesel. Founded by two friends Mr. R.S. Agarwal and Mr. R.S. Goenka, today Emami is a trusted brand of the nation with over 25,000 employees and with a group turnover of about Rs.100 Bn. is one of the leading and fastest growing personal and healthcare businesses in India, with an enviable portfolio of household brand names such as Boroplus, Navratna, Fair and Handsome, Zandu balm, Mentho Plus balm and Fast Relief. With seven manufacturing locations in India and one in Bangladesh supported by a widespread distribution network, the company is positioned to make its products available in every corner of the country. Emami has received countless accolades for its innovative and clutter-breaking products, which have carved out whole new segments from scratch in the Indian FMCG space and positioned the company as one of the fastest growing and most profitable companies in the sector. Cash Flow (Rs. Mn) FY15 FY16E FY17E FY18E PBT* Depreciation Tax (956) (1309) (1577) (1935) Changes in WC 734 (282) 15 8 Others (705) (1092) (1265) (1464) CF from Operations Capex (1098) (500) (844) (887) Investments (18111) (1000) (1000) (1000) Others CF from Investing (2337) (361) (531) (375) Change in Debt Interest Paid (52) (51) (51) (51) Dividends & Others (2120) (2523) (3038) (3729) CF from Financing (2154) (2575) (3090) (3780) Change in Cash , * Before Exceptional Item Exhibit 3: Geography-wise Revenue Segmentation - FY15 (%) Promoters 72.7% FIIs 16.3% DIIs 1.2% Others 9.8% Domestic 85.7% International 14.3% Source: BSE, Karvy Research 2
3 High Margin Products in the Portfolio are expected to drive EBITDA growth ahead of Sales growth: Exhibit 4: Revenue & EBITDA Growth (%) 25% 15% 10% 5% 0% 16.6% 16.9% 7.2% Apr 30, 2016 Marching ahead in the league of Herbal Products: Zandu accounts for ~25% of the total revenue of Emami, with over 200 products in the portfolio under the Zandu Brand. The company is also expected to extend the brand with couple of new products; with the most recent launch of Zandu Honey, Emami is currently test marketing these new products and it is expected to launch these products by the end of FY17E. The company has also launched new products in diabetes space, heart care and also related to stress. These products are under test marketing in South India. The company foresees huge potential in this segment as there is no organized market and can create market for these brands. Balms and pain relief segment: Pain relief is a segment of focus for Emami. The company owns home-grown brands like Mentho Plus Balm, Fast Relief and category leader Zandu Balm. The pain relief category accounted for 21% of Emami s consolidated sales in FY15. Ayurvedic positioning and widening rural presence made it possible for these brands to capture the largest market share in these categories. Market Leader of Cooling Hair oil is beating the Heat: The best seller of all times, Emami s Navratna cooling oil enjoys around 60% of the total market share. The rising temperature across India is expected to give robust growth to its Navratna cooling oil, Navratna Cool Talc and to Boroplus prickly heat powder. Historically, cooling oil has recorded 16% to 17% growth during moderate summer, so considering the current weather condition, it is expected to grow at good pace. Hair oils: Emami plugged a gap in its portfolio through the introduction of Emami 7 Oils in One, a unique oil formula combining seven Ayurvedic ingredients which are effective for strong and healthy hair growth targeting young girls and women. Cool oil: Emami catalysed the cool oil category in India through Navratna Oil, enjoying ~60% market share by volume and 65.5% share by value. The company is an undisputed leader in the cooling oil category. Exhibit 5: Key Brands & Presence % 12.7% 11.8% 21.8% 14.3% 7.5% 7.1% 20.9% 23.5% 16.3% 17.1% FY12 FY13 FY14 FY15 FY16E FY17E FY18E Revenue Growth (%) EBITDA Growth (%) 60.5% % % % % 11.0% 13.0% 15.0% Navratna Boroplus Zandu Fair & Handsome 80% 60% 40% Market Size (Rs. Mn) CAGR (5yrs) (RHS) Market Share (%) (RHS) 0% Recent acquisition of Kesh King Brand, accounts for around 75% gross margin and 45% EBITDA margin as compared to the other products in the portfolio. Kesh King Brand is expected to drive the top line growth by around 8% to 10% additionally. This will enable Emami to record higher margins in FY17E and FY18E. Emami has also launched new Stock Keeping Units (SKUs) to increase the rural penetration targeting middle age women. Exhibit 6: Penetration Level (%) 80% 60% 40% 0% 17.0% 26.0% 32.0% 70.0% Navratna Boroplus Zandu Fair & Penetration (%) Handsome It is observed that Emami enjoys market leadership position across all the brands. The fastest growing category amongst all is the Navratna Brand growing at 17% CAGR in last 5 years. However, Navratna has very low penetration across India. The major market for Navratna cooling oil is North India. With low penetration of Navratna and being the market leader, it is expected to grow at high pace. 3
4 Skin care: Skin care accounted for around of Emami s revenues and a higher share of profits. Emami is the leader in the antiseptic cream category and in the men s fairness cream segment which it pioneered. Its Navratna Cool Talc (niche cooling positioning) has substantially increased market share in the cool talc category. Strong Balance Sheet: With very moderate level of capital expenditure required in the business, Emami has very strong balance sheet, earning an average RoE of 42.9% & RoCE of 40.7% in last 4 years. Emami enjoys negative working capital for FY15 and expects to maintain at same level, which is healthy sign for any business. Its average net debt to equity is -0.3x for last 4 years on consolidated basis. International Business: Exhibit 7: International Market Share (%) 100% 80% 93.0% 91.0% 60% 40% 47.0% 45.0% 37.0% 30.0% 0% Navratna Fair & Handsome UAE Saudi Arabia Bangladesh The international business of Emami contributes around 17% of the total revenue; the international business has recorded 16% CAGR from FY11 to FY15, during Q3FY16 international business grew by 11% and by 14% in 9MFY16. Emami also enjoys leadership position in international markets; the Navratna cooling oil and Fair & Handsome dominate the markets across UAE, Saudi Arabia and Bangladesh. The company expects robust growth in top line from international business going forward. Exhibit 8: Geography-wise Revenue Segmentation - Q3FY16 (%) Exhibit 9: International Revenue Segmentation (%) MENAP 35.0% Domestic 83.0% International 17.0% SAARC & SEA 44.0% CISEE 12.0% Others 9.0%, MENAP: Middle East, North Africa & Pakistan SAARC & SEA: South Asian Association for Regional Cooperation & South East Asia CISEE: Commonwealth of Independent States & Eastern Europe Summary: Emami has been an interesting growth story in the Indian FMCG sector with a net profit CAGR of more than in the last five years. We expect that Emami is better positioned for faster growth; driven by (1) its entry into new categories, (2) scale up of the Zandu Health Care Division (HCD) and (3) growth in international business. Emami looks well placed with strategy of innovation and creation of strong portfolio of niche products, many of which are based on traditional ayurvedic formulations. Most of these products have high gross margins - highest among domestic peers, along with the low penetration of most of its categories, gives the opportunity for strong growth in the years ahead. We expect Emami s top line to grow at 17% CAGR over FY17E-FY18E assisted along with new launches like She feminine hygiene, HE deodorants, etc. to contribute to additional revenue growth. 4
5 Exhibit 10: Business Assumptions Y/E Mar (Rs. Mn) FY15 FY16E FY17E FY18E Comments Revenue Revenue Growth (%) EBITDA EBITDA Margins (%) PAT (normalized) Fully Diluted EPS (Rs.) Fully Diluted EPS Growth (%) Capex (ex. Acquisition) - cash capex (1098) (500) (844) (887) Net CFO Net Debt (3347) (4852) (6716) (9321) Free Cash Flow We expect that Emami is better positioned for faster growth; driven by (1) its entry into new categories, (2) scale up of the Zandu Health Care Division (HCD) and (3) growth in international business, along with the low penetration of most of its categories, give the opportunity for strong growth in the years ahead. We expect Emami s top line to grow at 17% CAGR over FY17E-FY18E assisted along with new launches like She feminine hygiene, HE deodorants, etc. to contribute to additional revenue growth. Most of the products of Emami have high gross margins - highest among domestic peers, the recent acquisition of Kesh King, which has around 75% gross margin, is expected to drive the EBITDA growth ahead of Sales growth. Emami has been an interesting growth story in the Indian FMCG sector with a net profit CAGR of more than in the last five years. With high gross margin products in the portfolio and better product mix, Emami has earned more than PAT and it is expected to grow at ~22% CAGR from FY17E-FY18E. Emami s EPS has registered CAGR of 9.1% from FY11 to FY15 and it is expected to register double digit growth during FY17E and FY18E. Emami has very strong balance sheet, earning an average RoE of 42.9% & RoCE of 40.7% in last 4 years, it is expected to maintain its RoE and RoCE at same level going forward. Exhibit 11: Karvy vs Consensus Revenues (Rs. Mn) Karvy Consensus Divergence (%) Comments FY16E (4.3) We have moderate outlook on volume and realizations growth. Revenue is expected to grow at CAGR of 16.7% during FY17E (7.0) FY16E-18E. PAT (Rs. Mn) FY16E FY17E EPS (Rs.) With a net profit CAGR of more than in the last five years and with high gross margin products in the portfolio and better product mix, Emami has earned more than PAT and it is expected to grow at ~22% CAGR from FY17E-FY18E. FY16E Emami s EPS has registered CAGR of 9.1% from FY11-FY15 and it is expected to register double digit growth during FY17E FY17E and FY18E. 5
6 Exhibit 12: Revenue (Rs. Mn), Revenue Growth (%) % 17.1% 21.8% 16.9% 14.3% 7.2% FY13 FY14 FY15 FY16E FY17E FY18E 10% 0% Revenue (Rs. Mn) YoY Growth (%) We expect that Emami is better positioned for faster growth driven by (1) its entry into new categories, (2) scale up of the Zandu Health Care Division (HCD) and (3) growth in international business, along with the low penetration of most of its categories, give the opportunity for strong growth in the years ahead. We expect Emami s top line to grow at 17% CAGR over FY17E-FY18E assisted along with new launches like She feminine hygiene, HE deodorants, etc. to contribute to additional revenue growth. Most of the products of Emami have high gross margins - highest among domestic peers, the recent acquisition of Kesh King, which has around 75% gross margin, is expected to drive the EBITDA growth ahead of sales growth. Exhibit 13: EBITDA (Rs. Mn), EBITDA Margin (%) % 25.0% 26.4% 24.4% 23.7% 22.8% % 26% 24% 22% 0 FY13 FY14 FY15 FY16E FY17E FY18E EBITDA (Rs. Mn) EBITDA Margin (%) Exhibit 14: EBIT (Rs. Mn), EBIT Margin (%) % 22.1% 25.9% 27.0% 26.0% 26.9% FY13 FY14 FY15 FY16E FY17E FY18E EBIT (Rs. Mn) EBIT Margin (%) 35% 25% Exhibit 15: PAT (Rs. Mn), PAT Margin (%) % 22.1% 21.9% 21.4% 20.7% 18.5% FY13 FY14 FY15 FY16E FY17E FY18E 25% 23% 18% 15% PAT (Rs. Mn) PAT Margin (%) Emami has been an interesting growth story in the Indian FMCG sector with a net profit CAGR of more than in the last five years. With high gross margin products in the portfolio and better product mix, Emami has earned PAT margin more than and it is expected to grow at ~22% CAGR from FY17E to FY18E. Exhibit 16: EPS (Rs.), RoE & RoCE (%) % 44.9% 42.4% 39.5% % 43.1% % 37.9% 38.1% 37.0% % 37.1% FY13 FY14 FY15 FY16E FY17E FY18E EPS (Rs.) (LHS) RoE (%) RoCE (%) 50% 45% 40% 35% 25% Emami s EPS has registered CAGR of 9.1% from FY11 to FY15 and it is expected to register double digit growth during FY17E and FY18E. Emami has very strong balance sheet, earning an average RoE of 42.9% & RoCE of 40.7% in last 4 years, it is expected to maintain its RoE and RoCE at same level going forward. 6
7 Exhibit 17: Company Snapshot (Ratings) Low High Quality of Earnings 33 Domestic Sales 33 Exports 33 Net Debt/Equity 33 Working Capital Requirement 33 Quality of Management 33 Depth of Management 33 Promoter 33 Corporate Governance 33 7
8 Valuation & Outlook At CMP of Rs.1007, the stock is trading at P/E of 29.5x for FY18E. With the anticipated increase in top line due to high margin products in the portfolio, rising temperature across India, strong brand positioning, innovation and new product launches which were favourably received by the market, with strong balance sheet & financial ratios, we expect that the consumer expenditure will further increase as the economy revives and hence there will be growth in Emami s top line and bottom line as well. Based on P/E of 38.5x, we initiate the coverage with a BUY rating for a Target Price of Rs.1313 representing an upside of for a period of months. Exhibit 18: PE Band Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 P/E Average 1SD 2SD -1SD -2SD Exhibit 19 (a): Comparative Valuation Summary CMP (Rs.) Mcap EV/EBITDA (x) P/E (x) EPS (Rs.) (Rs. Mn) FY15 FY16E FY17E FY15 FY16E FY17E FY15 FY16E FY17E GCPL Marico Ltd Exhibit 19 (b): Comparative Operational Metrics Summary CAGR % (FY15-17E) RoE (%) Price Perf (%) Net Sales (Rs. Mn) Sales EBITDA EPS FY15 FY16E FY17E 3m 6m 12m FY15 FY16E FY17E (0.1) (4.0) GCPL Marico Ltd
9 Peer Comparison Exhibit 20: Revenue Growth (%) Exhibit 21: EBITDA Margin (%) 25% 21.8% 27.6% 15% 10% 7.2% 14.3% 16.3% 25% 24.4% 22.8% 23.7% 5% 15% 0% FY14 FY15 FY16E FY17E Emami GCPL Marico 10% FY14 FY15 FY16E FY17E Emami GCPL Marico Exhibit 22: RoE (%) Exhibit 23: Dividend Payout Ratio (%) 50% 47.1% 44.9% 60% 54.4% 40% 38.3% 37.9% 50% 40% 45.0% 46.2% 38.7% 27.0% FY14 FY15 FY16E FY17E Emami GCPL Marico 10% FY11 FY12 FY13 FY14 FY15 Emami GCPL Marico Key Risks ycompetition. yvolatility in raw material prices. 9
10 Financials Exhibit 24: Income Statement YE Mar (Rs. Mn) FY14 FY15 FY16E FY17E FY18E Revenues Growth (%) Operating Expenses EBITDA Growth (%) Depreciation & Amortization Other Income EBIT Interest Expenses PBT Tax Adjusted PAT Growth (%) Exhibit 25: Balance Sheet YE Mar (Rs. Mn) FY14 FY15 FY16E FY17E FY18E Cash & Cash Equivalents Trade Receivables Inventories Loans & Advances & Others Investments Net Block Total Assets Current Liabilities & Provisions Debt Other Liabilities Total Liabilities Shareholders Equity Reserves & Surplus Total Networth Total Networth & Liabilities
11 Exhibit 26: Cash Flow Statement YE Mar (Rs. Mn) FY14 FY15 FY16E FY17E FY18E PBT (Before Exceptional Item) Depreciation Tax Paid (766) (956) (1309) (1577) (1935) Inc/dec in Net WC (282) 15 8 Other Income (586) (1491) (1093) (1267) (1466) Other non cash items Cash flow from operating activities Inc/dec in capital expenditure (654) (1098) (500) (844) (887) Inc/dec in investments (13052) (18111) (1000) (1000) (1000) Others Cash flow from investing activities (1419) (2337) (361) (531) (375) Changes in Debt (751) Dividend paid (2211) (2120) (2523) (3038) (3729) Interest paid (51) (52) (51) (51) (51) Effect of Forex Fluctuation 21 (35) Cash flow from financing activities (3013) (2154) (2575) (3090) (3780) Net change in cash (128) Exhibit 27: Key Ratios YE Mar FY14 FY15 FY16E FY17E FY18E EBITDA Margin (%) EBIT Margin (%) Net Profit Margin (%) Dividend Payout Ratio (%) Net Debt/Equity (x) (0.3) (0.3) (0.3) (0.4) (0.4) RoE (%) RoCE (%) Exhibit 28: Valuation Parameters YE Mar FY14 FY15 FY16E FY17E FY18E EPS (Rs.) DPS (Rs.) BV (Rs.) PE (x) P/BV (x) EV/EBITDA (x) EV/Sales (x) ; *Represents multiples for FY14 & FY15 are based on historic market price 11
12 Stock Ratings Absolute Returns Buy : > 15% Hold : 5-15% Sell : <5% Connect & Discuss More at (Toll Free) research@karvy.com Live Chat f in You Tube Disclaimer Analyst certification: The following analyst(s), Kunal Jagda, who is (are) primarily responsible for this report and whose name(s) is/are mentioned therein, certify (ies) that the views expressed herein accurately reflect his (their) personal view(s) about the subject security (ies) and issuer(s) and that no part of his (their) compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report. Disclaimer: Karvy Stock Broking Limited [KSBL] is a SEBI registered Stock Broker, Depository Participant, Portfolio Manager and also distributes financial products. KSBL has filed an application with SEBI, seeking registration as a Research Analyst and such application is pending for disposal. The subsidiaries and group companies including associates of KSBL provide services as Registrars and Share Transfer Agents, Commodity Broker, Currency and forex broker, merchant banker and underwriter, Investment Advisory services, insurance repository services, financial consultancy and advisory services, realty services, data management, data analytics, market research, solar power, film distribution and production, profiling and related services. Therefore associates of KSBL are likely to have business relations with most of the companies whose securities are traded on the exchange platform. The information and views presented in this report are prepared by Karvy Stock Broking Limited and are subject to change without any notice. This report is based on information obtained from public sources, the respective corporate under coverage and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of KSBL. While we would endeavor to update the information herein on a reasonable basis, KSBL is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent KSBL from doing so. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. KSBL will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. This material is for personal information and we are not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither KSBL nor any associate companies of KSBL accepts any liability arising from the use of information and views mentioned in this report. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Past performance is not necessarily a guide to future performance. Forward-looking statements are not predictions and may be subject to change without notice. Actual results may differ materially from those set forth in projections. y Associates of KSBL might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. y Associates of KSBL might have received compensation from the subject company mentioned in the report during the period preceding twelve months from the date of this report for investment banking or merchant banking or brokerage services from the subject company in the past twelve months or for services rendered as Registrar and Share Transfer Agent, Commodity Broker, Currency and forex broker, merchant banker and underwriter, Investment Advisory services, insurance repository services, consultancy and advisory services, realty services, data processing, profiling and related services or in any other capacity. y KSBL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. y Compensation of KSBL s Research Analyst(s) is not based on any specific merchant banking, investment banking or brokerage service transactions. y KSBL generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. y KSBL or its associates collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. y KSBL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report and have no financial interest in the subject company mentioned in this report. y Accordingly, neither KSBL nor Research Analysts have any material conflict of interest at the time of publication of this report. y It is confirmed that KSBL and Research Analysts, primarily responsible for this report and whose name(s) is/ are mentioned therein of this report have not received any compensation from the subject company mentioned in the report in the preceding twelve months. y It is confirmed that Kunal Jagda, Research Analyst did not serve as an officer, director or employee of the companies mentioned in the report. y KSBL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. y Neither the Research Analysts nor KSBL have been engaged in market making activity for the companies mentioned in the report. y We submit that no material disciplinary action has been taken on KSBL by any Regulatory Authority impacting Equity Research Analyst activities. Karvy Stock Broking Limited Plot No.31, 6th Floor, Karvy Millennium Towers, Financial District, Nanakramguda, Hyderabad, , India Tel: ; Fax: For More updates & Stock Research, visit 12
Fineotex Chemical Ltd
Company Update Decent Performance under Macroeconomic Pressure; Business Traction to Continue: Fineotex Chemical recorded decent set of result as consolidated sales grew by 1.1% YoY (largely in line) to
More informationVisaka Industries Ltd
Company Update Superior Product Mix & New Age Markets to Aid Growth New investments to aid growth: Visaka continues to give a good set of numbers. YoY EPS grew at 142% aided by a revenue growth of 1.5%
More informationCummins India Ltd Bloomberg Code: KKC IN
Company Update Margins Under Pressure; Domestic Recovery Underway Half-yearly revenue was flat; margins were under pressure: Cummins India revenue, EBITDA and PAT for H1FY17 reached to Rs.24,784mn, Rs.4,649mn
More informationSQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E
Company Update Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E EBITDA Margins recovered by 618 bps QoQ: The company has witnessed many challenges over the year FY17 starting
More informationPidilite Industries Ltd
Company Update De-stocking as an initial response to GST implementation caused subdued performance; Brighter long term business prospects ahead The company has recorded sales of Rs. 16693 Mn in as against
More informationVakrangee Ltd BUY. Speciality Retail. Company Update. Aug 07, Vakrangee Ltd. Recommendation (Rs.)
Company Update Speciality Retail Addition of Service Offerings will Ramp up the Business PAT increased by 38.3% YoY on strong revenue growth: During Q1FY18, the revenue stood at Rs. 13047 Mn as against
More informationSimplex Infrastructures
May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 India Research Infrastructure May 27, 2015 QUARTERLY REVIEW Bloomberg: SINF IN Reuters: SINF.BO HOLD Working capital ease to improve
More informationHindustan Unilever (RHS)
Jul-14 Aug-14 Oct-14 Nov-14 Dec-14 Feb-15 Mar-15 Apr-15 Jun-15 Jul-15 India Research FMCG July 22, 2015 QUARTERLY REVIEW Bloomberg: HUVR IN Reuters: HLL.BO SELL Higher A&P drove volume growth HUL s Q1FY16
More informationHCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.
Jan-14 Mar-14 Apr-14 May-14 Jul-14 Aug-14 Sep-14 Nov-14 Dec-14 Jan-15 India Research Infrastructure April 10, 2015 EVENT UPDATE Bloomberg: IN Reuters: HCNS.BO BUY QIP step in the right direction has successfully
More informationAhluwalia Contracts (India)
May-14 Jul-14 Aug-14 Sep-14 Oct-14 Dec-14 Jan-15 Feb-15 Apr-15 May-15 India Research Infrastructure May 22, 215 QUARTERLY REVIEW Bloomberg: AHLU IN Reuters: AHLU.BO BUY Better performance ahead ACIL posted
More informationIndag Rubber Ltd Bloomberg Code: IDR IN
Industrials-Transportation Equipment-Commercial Vehicles Bloomberg Code: IDR IN India Research - Stock Broking Set to Ride on Commercial Vehicle Growth with Strong Cash Flows and Balance Sheet Recovery
More informationBharat Electronics Ltd
Company Update Excellent Margins Led by Strong Revenue Growth Revenue Analysis: Total order backlog as on Oct 1, 216 stood at Rs. 347 Bn, out of this, export order back log is US$.1 Bn. Incremental orders
More informationThe Byke Hospitality Ltd
Consumer Discretionary-Gaming, Lodging & Restaurants Bloomberg Code: BYKE IN India Research - Stock Broking Unique Asset Light Business Model Continues to Scale New Heights Room inventory addition to drive
More informationPunjab National Bank
Nov-14 Dec-14 Jan-15 Mar-15 Apr-15 May-15 Jul-15 Aug-15 Sep-15 Nov-15 India Research Banking November 09, 2015 QUARTERLY REVIEW Bloomberg: PNB IN Reuters: PNBK.BO SELL Asset quality improves but recovery
More informationBloomberg Code: ATA IN
Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew
More informationPidilite Industries Ltd
Materials-Chemicals-Specialty Chemicals Bloomberg Code: PIDI IN India Research - Stock Broking Backed by Brands Like Fevicol, Scaling Up Leadership Position in Adhesives and Sealants Products on Economic
More informationSymphony Ltd. RESULT UPDATE 31st October 2017
. RESULT UPDATE 31st October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update Q2FY18 II 31st October 2017. CMP INR 1,465 Target INR 1,700 Potential
More informationBajaj Corp Ltd Bloomberg Code: BJCOR IN
Consumer Staples-Household Products Bloomberg Code: BJCOR IN India Research - Stock Broking In Pursuit of Excellence, with Almond Drops Hair Oil Leading position in Light Hair Oil market and Well established
More informationVakrangee Ltd Bloomberg Code: VKI IN
Jan 4, 216 Technology - Software - Infrastructure Software Jan 4, 216 Bloomberg Code: VKI IN India Research - Stock Broking Riding on Growing Impetus to Financial Inclusion Company to shift its focus from
More informationAutomobiles. Heading Into Strong Earnings Growth Quarter QUARTERLY PREVIEW
India Research April 19, 2018 QUARTERLY PREVIEW Mar'18 Quarterly PAT Company PAT (Rs mn) Maruti Suzuki 20,605 M&M 10,367 Hero MotoCorp 8,774 Bajaj Auto 11,253 TVS Motor 2,432 Ashok Leyland 6,472 Bharat
More informationITC Ltd. RESULT UPDATE 27th October, 2017
. RESULT UPDATE 27th October, 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 27th October, 2017 CMP INR 269 Target INR 349 Potential Upside
More informationNestle India Ltd. RESULT UPDATE
RESULT UPDATE 15th May 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update Q1CY17 II 15th May, 2017 CMP INR 6819 Target INR 7075 Potential Upside
More informationColgate-Palmolive India Ltd.
RESULT UPDATE 5th February, 2018 Feb-15 Aug-15 Feb-16 Aug-16 Feb-17 Aug-17 Feb-18 India Equity Institutional Research II Result Update - Q3FY18 II 5th February, 2018 CMP INR 1,120 MARKET DATA Target INR
More informationCompany Overview. Industry Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Trade Wings Limited CMP: 105.00 January 29, 2016 Stock Details BSE code 509953 BSE ID TRADWIN Face value ( ) 10 No of
More informationCompany Overview. Industry Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 27.80 January 20, 2016 Stock Details BSE code 534623 BSE ID JUPITERIN Face value ( ) 10 No of shares (m) 10 52 week
More informationProcter & Gamble Hygiene & Health Care
3QFY216 Result Update FMCG May 6, 216 Procter & Gamble Hygiene & Health Care Performance Highlights Quarterly Data (` cr) 3QFY16 3QFY15 % yoy 2QFY16 % qoq Revenue 614 555 1.5 714 (14.) EBITDA 133 123 8.5
More informationPrabhat Dairy Ltd. RESULT UPDATE 8th June, 2018
RESULT UPDATE 8 th June, 2018 Sep-15 Jan-16 May-16 Sep-16 Jan-17 May-17 Sep-17 Jan-18 May-18 India Equity Institutional Research II Result Update - Q4FY18 II 8 th June, 2018 2 Under Expansion Mode CMP
More informationCompany Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 CMP: 32.30 February 11, 2016 Stock Details BSE code 526558 BSE ID JAMEHOT Face value ( ) 10 No of shares (m) 8.0 52 week
More informationCompany Overview. Financial Performance
Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Feb/16 Mar/16 Monarch Networth Capital Limited CMP: 26.00 March 23, 2016 Stock Details BSE code 511551 BSE ID MONARCH Face value (
More informationSQS India BFSI Ltd BUY. World s Leading Specialist in Financial Services Testing. Valuation and Outlook. Key Risks
Technology - Application Software Bloomberg Code: SQSI IN India Research - Stock Broking World s Leading Specialist in Financial Services Testing Benefits from SQS Group drive growth opportunities: SQS
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/ Apr/15 May/ Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/ Dec/15 Parnax Lab Limited CMP: 53.90 January 08, 2016 Stock Details BSE code 506128 BSE ID PARNAXLAB Face value ( ) 10 No of shares
More informationCompany Overview. Financial Performance
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Nimbus Projects Limited CMP: 34. December 4, 15 Stock Details BSE code 511714 BSE ID NIMBSPROJ Face value ( ) 1 No of
More informationTata Motors BUY. New Products at JLR to Drive Profitability Favorable Exchange to Benefit Going Forward; Automobiles August 29, 2016
Aug15 Oct15 Nov15 Dec15 Feb16 Mar16 Apr16 Jun16 Jul16 Aug16 Institutional Equities India Research Automobiles August 29, 2016 RESULT REVIEW Bloomberg: TTMT IN Reuters: TAMO.BO New Products at JLR to Drive
More informationBritannia Industries Ltd.
. RESULT UPDATE 30th May, 2017 May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 India Equity Institutional Research II Result Update - Q4FY17 II 30 th May, 2017 2 Growth Path ahead CMP INR 3419 Target
More informationBritannia Industries Ltd Bloomberg Code: BRIT IN
Consumer Staples - Consumer Products - Packaged Food Jan 6, 216 Bloomberg Code: BRIT IN India Research - Stock Broking Delicious Brand, Backed by Healthy Financials Increasing outlets to penetrating into
More informationTata Elxsi Ltd BUY. Outlook & Valuation
Company Update Exhibit 1: Valuation Summary Technology - Software Bloomberg Code: TELX IN India Research - Stock Broking Consistent Performance Bolstered by Affluent Financials; Recently Entered Ventures
More informationAstra Microwave Products
Aug-13 Oct-13 Dec-13 Feb-14 Apr-14 Jun-14 Aug-14 Research Desk Stock Broking Capital Goods - Defence August 4, 2014 RESULT REVIEW Bloomberg: ASTM@IN Reuters: ASTM.BO Results in-line with expectation-maintain
More informationEmami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015
RESULTS REVIEW 4QFY15 14 MAY 2015 Emami NEUTRAL INDUSTRY FMCG CMP (as on 13 May 2015) Rs 937 Target Price Rs 910 Nifty 8,235 Sensex 27,251 KEY STOCK DATA Bloomberg/Reuters HMN IN/EMAM.BO No. of Shares
More informationBritannia Industries Ltd.
. RESULT UPDATE 9th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now
More informationHindustan Unilever Ltd.
. RESULT UPDATE 18 th July 2017 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17 Jul-17 125 105 India Equity Institutional Research II Result Update - FY18 II 18th July, 2017 CMP INR 1158 Target INR 1206 MARKET
More informationCompany Overview. Financial Performance
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 CMP: 25.20 December 30, 2015 Stock Details BSE code 524440 BSE ID CAMEXLTD Face value ( ) 10 No of shares (m) 10.2 52
More informationTVS Motors. Source: Company Data; PL Research
Margins trajectory looking up ; Accumulate November 01, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating Accumulate Price Rs709
More informationGarware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months
2QFY217 Result Update Textile November 16, 216 Garware Wall Ropes Performance Highlights Quarterly Data (`cr) 2QFY17 2QFY16 % yoy 1QFY17 % qoq Revenue 232 214 8.5 225 3.3 EBITDA 4 26 5.9 31 29.4 Margin
More informationColgate-Palmolive (India)
Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue
More informationBloomberg Code: FNXP IN
Feb 3, 215 Consumer Goods - Non Durable Finolex Industries Feb 3, 215 Ltd India Research Stock Broking Bloomberg Code: FNXP IN Shift in business & backward integration to accelerate growth (FIL) could
More informationAmber Enterprises India Ltd
3QFY2019 Result Update Consumer Durable February 16, 2019 Amber Enterprises India Ltd Performance Update (` cr) 3QFY19 3QFY18 % yoy 2QFY19 % qoq Revenue 388.8 338.4 14.9 226.3 71.8 EBITDA 22.1 24.1 (8.2)
More informationSuzlon Energy Ltd RESULT UPDATE 16th August, 2017
RESULT UPDATE 16 th August, 2017 Aug-16 Oct-16 Dec-16 Feb-17 Apr-17 Jun-17 Aug-17 Please vote for us in Asiamoney Brokers Poll 2017: https://www.euromoney.com/article/b13j49qfcr6j pp/asiamoney-brokers-poll-2017-vote-now
More informationCompany Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 KMC Speciality Hospitals India Ltd CMP: 7.61 January 21, 2015 Stock Details BSE code 524520 BSE ID KMCSHIL Face value
More informationGrindwell Norton Ltd Bloomberg Code: GWN IN
Aug 2, 21 Materials - Abrasives Aug 2, 21 Bloomberg Code: GWN IN India Research - Stock Broking GWN is set to rise with resilient economy Up-tick in industrial and investment activity could steer revenues
More informationGillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance
2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings
More informationAsian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics
3QFY2017 Result Update Ceramics January 25, 2017 Asian Granito Performance Highlights Quarterly Data (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Revenue 247 236 4.3 265 (7.1) EBITDA 34 27 25.3 31 7.2 Margin
More informationReligare Investment Call
v-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 v-18 Q2FY19 Result Update Q2FY19 Result Update BUY CMP (Rs) 5,813 Target Price (Rs) 6,519 Potential Upside 12.1% Sensex
More informationMaruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research
In a league of its own ; Buy October 28, 2017 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs8,115 Target Price Rs9,250
More informationChange EPS. (Rs) FY
17 AUG 217 / Quarterly Update BUY Target Price: Rs. 662 : Revenue up 21% Y-o-Y, strong growth in Non-GLE segment GMM Pfaudler Ltd(GMM) in 1QFY18posted revenues of Rs 69 Cr. (up 21% Y-o-Y, down 13% Q-o-Q)
More informationMaruti Suzuki. Source: Company Data; PL Research
Healthy operating performance; Accumulate October 28, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs5,860 Target Price Rs6,356 Implied Upside 8.5% Sensex 27,916 Nifty
More informationCompany Overview. Financial Performance
Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 Jan/16 Eastern Treads Ltd CMP: 91.20 February 11, 2016 Stock Details BSE code 531346 BSE ID EASTRED Face value ( ) 10 No of
More informationCummins India. Growth/margin bottoming. Source: Company Data; PL Research
Growth/margin bottoming May 25, 2018 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Shreyans Jain shreyansjain@plindia.com +91 22 66322256 Rating BUY Price Rs704 Target Price Rs928 Implied Upside 31.8%
More informationHindustan Media Ventures
2QFY216 Result Update Media October 27, 215 Hindustan Media Ventures Performance Highlights Quarterly Data (` cr) 2QFY16 2QFY15 % yoy 1QFY15 % qoq Revenue 227 2 13.7 224 1.4 EBITDA 52 39 33.1 55 (4.5)
More informationGoodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials
1QCY212 Result Update Tyres June 6, 212 Goodyear India Performance Highlights Y/E December (` cr) 1QCY212 1QCY211 % chg (yoy) 4QCY211 % chg (qoq) Net sales 331 336 (1.6) 395 (16.2) EBITDA 2 24 (18.6) 34
More informationMahindra & Mahindra Ltd.
Nov-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 2QFY2019 Result Update Automobile November 15, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)
More informationMahindra & Mahindra Ltd.
Jan-16 Apr-16 Jul-16 Oct-16 Jan-17 Apr-17 Jul-17 Oct-17 Jan-18 Apr-18 Jul-18 Oct-18 Jan-19 3QFY2019 Result Update Automobile February 15, 2019 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr)
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Shri Jagdamba Polymers Ltd. CMP: 44.2 January 15, 216 Stock Details BSE code 512453 BSE ID SHRJAGP Face value
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 CMP: 31.25 December 24, 2015 Stock Details BSE code 523878 BSE ID TOTEX Face value ( ) 10 No of shares (m) 8.1 Market
More informationCompany Overview. Financial Performance
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Superior Industrial Enterprises Limited CMP: 19.6 December 24, 215 Stock Details BSE code 519234 BSE ID SIEL Face value
More informationQuick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.
Ltd. Creating value through paper Limited (RPL) manufactures writing paper, printing paper and Kraft paper. The company's white writing and printing paper is used in making notebooks and writing material,
More informationHero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart
3QFY2017 Result Update Automobile February 14, 2017 Hero MotoCorp Performance Highlights ACCUMULATE CMP `3,226 Target Price `3,466 Y/E March (` cr) 2QFY17 2QFY16 % chg (yoy) 1QFY17 % chg (qoq) Investment
More informationMaruti Suzuki (RHS) BUY. Operationally In Line; Reiterate Buy. Automobiles October 31, 2014 RESULT REVIEW. Outlook & Valuation.
Oct13 Dec13 Jan14 Feb14 Apr14 May14 Jun14 Aug14 Sep14 Oct14 India Research Automobiles RESULT REVIEW Bloomberg: MSIL IN Reuters: MRTI.BO BUY Operationally In Line; Reiterate Buy India s (MSIL) Revenue/EBIDTA/PAT
More informationCompany Overview. Financial Performance
Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Anisha Impex Ltd CMP: 11.85 December 31, 2015 Stock Details BSE code 537785 BSE ID Face value ( ) 10 No of shares (m)
More informationBlue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.
Aug-15 Oct-15 Dec-15 Feb-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Jan-17 Apr-17 May-17 Jul-17 Sep-17 Nov-17 Jan-18 Mar-18 May-18 Jul-18 1QFY2019 Result Update Cons. Durable August 10, 2018 Blue Star Ltd Performance
More informationSiemens. Railways and T&D driving inflows. Source: Company Data; PL Research
Railways and T&D driving inflows November 23, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs1,055 Target Price Rs1,230
More informationJamna Auto Industries
2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were
More informationWabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research.
Management Meet Note Rating matrix Rating : Buy Target : 6750 Target Period : 12 months Potential Upside : 14% What s Changed? Target Changed from 6400 to 6750 EPS FY17E Unchanged EPS FY18E Unchanged Rating
More informationITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months
3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630
More informationMRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials
Company Update Automobile February 22, 212 MRF Performance Highlights Y/E Sept. (` cr) 1QSY12 1QSY11 % chg (yoy) 4QSY11 % chg (qoq) Net sales 2,875 2,167 32.7 2,62 9.8 EBITDA 258 243 5.9 181 42.6 EBITDA
More informationBharat Electronics Ltd Bloomberg Code: BHE IN
Industrials - Aerospace & Defense - Aircraft & Parts Oct 13, 215 Bloomberg Code: BHE IN India Research - Stock Broking Mirroring India s Defence Ambitions Turnaround for BEL on the backdrop of Government
More informationGAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -
2QFY2013 Result Update Oil & Gas October 26, 2012 GAIL India Performance Highlights Quarterly highlights (Standalone) Y/E March (` cr) 2QFY2013 2QFY2012 % chg (yoy) 1QFY2013 % chg (qoq) Net sales 11,361
More informationEmami Ltd. EDELSTAR FUNDAMENTAL RESEARCH
Emami Ltd. EDELSTAR FUNDAMENTAL RESEARCH Business Overview Emami is a leading FMCG player in India, operating in certain attractive segments such as skin care and hair oil. The company is promoted by Kolkata
More informationMphasis. Increased confidence on margins. Source: Company Data; PL Research
Increased confidence on margins July 25, 2016 Govind Agarwal govindagarwal@plindia.com +91 22 66322300 Rating BUY Price Rs540 Target Price Rs570 Implied Upside 5.6% Sensex 28,095 Nifty 8,636 (Prices as
More informationBUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights
JK 20 NOV 2017 Quarterly Update BUY Target Price: Rs 1,220 White cement steals the show JK Cement s (JKCE) Q2FY18 EBITDA at Rs 2.1 bn (up 30% YoY) was higher than our and consensus estimates, mainly due
More informationColgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD
Colgate-Palmolive Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin Sector: FMCG CMP: ` 1,063 Recommendation: HOLD Market Statistics Current stock price (`) 1,063 Shares O/S (cr.) 27.2
More informationMarico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015
RESULTS REVIEW 4QFY15 29 APR 2015 Marico Kaya INDUSTRY FMCG CMP (as on 28 Apr 2015) Rs 1,635 Target Price Rs 1,823 Nifty 8,240 Sensex 27,226 KEY STOCK DATA Bloomberg MAKA IN No. of Shares (mn) 13 MCap
More informationMahindra & Mahindra. Source: Company Data; PL Research
Tractors drive Q2 performance; Accumulate November 11, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating Accumulate Price Rs1,242 Target Price Rs1,503 Implied Upside 21.0% Sensex 26,819 Nifty
More informationHindustan Unilever Ltd.
. RESULT UPDATE 25th October 2017 Oct-14 Apr-15 Oct-15 Apr-16 Oct-16 Apr-17 Oct-17 India Equity Institutional Research II Result Update - II 25th October 2017 CMP INR 1273 Target INR 1392 Potential Upside
More informationCummins India. Source: Company Data; PL Research
Technology leadership, cost optimization key focus October 28, 2016 Kunal Sheth kunalsheth@plindia.com +91 22 66322257 Samir Bendre samirbendre@plindia.com +91 22 66322256 Rating Accumulate Price Rs852
More informationParag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months
2QFY2019 Result Update Dairy Products November 6, 2018 Parag Milk Foods Performance Update Y/E March (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 573 505 13.7% 549 4.4% EBITDA 58 50 16.3% 60-2.7%
More informationVST Industries Ltd BUY. Leader in Lower Price Range Cigarette Products
Consumer Staples - Food Beverage & Tobacco Bloomberg Code: VST IN India Research - Stock Broking Leader in Lower Price Range Cigarette Products Soaring Demand for Lower Price Range Cigarettes to Further
More informationAdani Ports & SEZ Rating: Target price: EPS:
Adani Ports & SEZ : price: EPS: Volume traction continues in a seasonally good quarter; maintain Adani Ports & SEZ reported a good quarter with total operating revenues (standalone) of Rs. 8.02bn and PAT
More informationDr. Lal Path Labs Ltd
Health Care-Health Care Facilities & Svcs Bloomberg Code: DLPL IN India Research - Stock Broking Strong Position in North India, Expanding in South and West Regions: Dr. Lal Path Labs is the second largest
More informationExide Industries BUY. Auto Components February 03, Volume Recovery & Cost Saving to Cushion Margins RESULT UPDATE
Feb-14 Mar-14 Apr-14 Jun-14 Jul-14 Aug-14 Oct-14 Nov-14 Dec-14 Jan-15 Institutional Equities India Research Auto Components February 03, 2015 RESULT UPDATE Bloomberg: EXID IN Reuters: EXID.BO BUY Volume
More informationMahindra & Mahindra Ltd.
May-15 Aug-15 Nov-15 Feb-16 May-16 Aug-16 Nov-16 Feb-17 May-17 Aug-17 Nov-17 Feb-18 4QFY2018 Result Update Automobile May 30, 2018 Mahindra & Mahindra Ltd. Performance Update Y/E March (` cr) 4QFY18 4QFY17
More informationHOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance
RAMCO S HOLD Target Price: Rs 503 Deleveraging story playing out Ramco Cements total debt reduced by a massive Rs 5 bn to Rs 22 bn in FY16. The company generated total EBITDA of Rs 11.5 bn in FY16 and
More informationCompany Overview. Industry Overview. Financial Performance
Jan/15 Feb/15 Mar/15 Apr/15 May/15 Jun/15 Jul/15 Aug/15 Sep/15 Oct/15 Nov/15 Dec/15 CMP: 6.22 January 18, 2016 Stock Details BSE code 526735 BSE ID EXCAST Face value ( ) 2 No of shares (m) 41 52 week H/L
More informationGMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months
2QFY2019 Result Update Industrial Machinery October 26, 2018 GMM Pfaudler Limited Performance Update Standalone (` cr) Q2FY19 Q2FY18 % yoy Q1FY19 % qoq Net sales 99.2 93.2 29.8% 76.4 6.4% EBITDA 16.0 15.3
More informationRallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart
3QFY2017 Result Update Agrichemical January 25, 2017 Rallis India Performance Highlights Y/E March (` cr) 3QFY2017 2QFY2017 % chg (qoq) 3QFY2016 % chg (yoy) Net sales 326 540 (39.7) 306 6.5 Other income
More informationBUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.
At inflection point Q2FY18 adjusted PAT grew 12% YoY at Rs 27 bn (vs. our estimate Rs 26 bn) in tandem with 17% YoY rise in regulated equity. Core RoE is still healthy at 20.2% though it contracted ~174
More informationRallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months
Jan-12 Jun-12 Nov-12 Apr-13 Sep-13 Feb-14 Jul-14 Dec-14 May-15 Oct-15 Mar-16 Aug-16 Jan-17 Jun-17 Nov-17 2QFY2018 Result Update Agrichemical November 21, 2017 Rallis India Performance Highlights Y/E March
More informationMaruti Suzuki. Source: Company Data; PL Research
Run continues, Royalty reduction positive ; Buy January 29, 2018 Saksham Kaushal sakshamkaushal@plindia.com +91 22 66322235 Poorvi Banka poorvibanka@plindia.com +91 22 66322426 Rating BUY Price Rs9,277
More informationSwaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE
2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above
More informationCompany Overview. Industry Overview. Financial Performance
CMP: 6.31 January 25, 2016 Stock Details BSE code 533100 BSE ID PEIL Face value ( ) 10 No of shares (m) 41 52 week H/L 17.70/4.03 Market cap ( m) 261 30 days avg vol (No) 1,156 Free float ( m) 89 Stock
More informationBajaj Electricals Ltd
Consumer Discretionary-Home & Office Products Bloomberg Code: BJE IN India Research - Stock Broking Recovery in Core Businesses to Drive Growth With most of the legacy orders near completion coupled with
More information